IART Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon.

$62.64  -1.01 (-1.59%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  08/16/1995
Outstanding shares:  84,699,539
Average volume:  302,574
Market cap:   $5,391,125,657
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    457985208
ISIN:        US4579852082
Sedol:      2248693
Valuation   (See tab for details)
PE ratio:   24.53
PB ratio:   3.25
PS ratio:   3.53
Return on equity:   13.26%
Net income %:   14.19%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy